Skip to main content
Home
Home

State of the State for Investment Funds in COVID-19 Era – Success of Specialized Funds in Venture Capital and Private Equity

State of the State for Investment Funds in COVID-19 Era – Success of Specialized Funds in Venture Capital and Private Equity

Science Chemicals EER

Large multistage and multisector funds with brand recognition can always raise another investment vehicle. 

However, given that the number of funds in venture capital and private equity have increased, funds with specialized focus, either in industry, stage, or investment thesis, are also having success in fundraising. This is due to their ability to attract a high quality deal flow and to deploy downside protection across their portfolio in times such as the COVID-19 pandemic.

Join us for a timely discussion with key industry thought leaders representing several funds as we examine the climate for investment funds' activities, their fundraising, LP relationships, and the special circumstances that may be affecting their portfolio companies, both positively and negatively.

Wednesday, October 28, 2020
10:00 a.m. - 11:30 a.m. PT | 1:00 p.m. - 2:30 p.m. ET


Moderator

  • Jesse Kanach 
    Partner, Perkins Coie

Speakers include:

  • Arman Pahlavan
    Partner, Perkins Coie
  • Jeff Mansukhani
    Southwest/West regional head of the Endowment & Foundation, Cambridge Associates
  • Eric Benhamou
    Founder & General Partner, BGV
  • Patrick Dunleavy
    Nanaging Director, Moelis & Company
  • Matthew Stepan
    Associate Director, Comprehensive Financial Management

Home
Jump back to top